STROMECTOL Drug Patent Profile
✉ Email this page to a colleague
When do Stromectol patents expire, and what generic alternatives are available?
Stromectol is a drug marketed by Merck Sharp Dohme and is included in one NDA.
The generic ingredient in STROMECTOL is ivermectin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stromectol
A generic version of STROMECTOL was approved as ivermectin by EDENBRIDGE PHARMS on October 24th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STROMECTOL?
- What are the global sales for STROMECTOL?
- What is Average Wholesale Price for STROMECTOL?
Summary for STROMECTOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 23 |
| Patent Applications: | 4,045 |
| Drug Prices: | Drug price information for STROMECTOL |
| What excipients (inactive ingredients) are in STROMECTOL? | STROMECTOL excipients list |
| DailyMed Link: | STROMECTOL at DailyMed |
Recent Clinical Trials for STROMECTOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jennifer Keiser | Phase 2 |
| Public Health Laboratory Ivo de Carneri | Phase 2 |
| Permamed AG, Switzerland | Early Phase 1 |
Pharmacology for STROMECTOL
| Drug Class | Antiparasitic Pediculicide |
US Patents and Regulatory Information for STROMECTOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | STROMECTOL | ivermectin | TABLET;ORAL | 050742-002 | Oct 8, 1998 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Merck Sharp Dohme | STROMECTOL | ivermectin | TABLET;ORAL | 050742-001 | Nov 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
